Literature DB >> 28038693

Motivations for Compliance With Bracing in Adolescent Idiopathic Scoliosis.

Elizabeth M Brigham1, Douglas G Armstrong2.   

Abstract

STUDY
DESIGN: Cross-sectional study.
OBJECTIVE: To determine motivations for compliance with bracing among female patients with adolescent idiopathic scoliosis (AIS). SUMMARY OF BACKGROUND DATA: Bracing prevents the need for surgery for the majority of girls with AIS with curves of 20° to 40° and 2 or more years of growth remaining. The main obstacle to success is compliance. The factors that either promote or impede compliance previously have not been fully clarified.
METHODS: Participants were females 10 to 16 years of age who were prescribed a brace to be worn 16 hours per day for AIS. Each completed a "Scoliosis Compliance Questionnaire" composed of the SRS-22r and five original sections focused on patients' attitudes to scoliosis, situations in which they found wearing the brace to be most and least difficult, factors that motivate brace wear, and interventions that could potentially improve compliance.
RESULTS: Thirty-nine subjects completed the study, mean age 13 years (range 11-15 years), at a mean of 15.4 months (range 4-39 months) of brace wear at the time of recruitment. More than 90% of patients stated that their main motivations for compliance were the desire to avoid surgery and to prevent curve progression. Compliance was most challenging during the summer and while at school. Many patients reported pain and skin irritation in the brace. The majority reported they would likely improve their hours of wear if they were able to communicate with a peer in the same situation. SRS-22r scores were similar to those of healthy adolescents.
CONCLUSIONS: The most important influences promoting brace wear are the patient's desire to avoid surgery and to prevent curve progression. Peer support potentially may improve compliance. LEVEL OF EVIDENCE: Level III.
Copyright © 2016 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; Bracing; Compliance; Females; Treatment

Year:  2017        PMID: 28038693     DOI: 10.1016/j.jspd.2016.09.004

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  6 in total

1.  In-Brace versus Out-of-Brace Protocol for Radiographic Follow-Up of Patients with Idiopathic Scoliosis: A Retrospective Study.

Authors:  Charles M M Peeters; Arthur J van Hasselt; Frits-Hein Wapstra; Paulus C Jutte; Diederik H R Kempen; Christopher Faber
Journal:  Children (Basel)       Date:  2022-03-25

2.  Assessment of Quality of Life for Scheuermann's Kyphosis Patients with Cobb's Angle 50°-65° Treated Conservatively or Surgically in North Jordan: A Prospective Comparative Study.

Authors:  Ziad Ali Audat; Khalid Ahmed Kheirallah; Bayan Faisal Ababneh; Hisham Zaidon Aljamal; Jomana Waleed Alsulaiman; Yaman Sameer Bataineh; Mohammad Moneer Algharibeh; Abdarrahman Ziad Audat
Journal:  Clin Orthop Surg       Date:  2022-03-03

3.  [The preliminary clinical application of a smart orthosis personalized management system for the treatment of patients with adolescent idiopathic scoliosis].

Authors:  Ce Zhu; Qiang Wu; Bing Xiao; Juehan Wang; Chao Luo; Quan Yu; Limin Liu; Yueming Song
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-07-15

4.  Actigraphy-based Sleep Parameters and Rest-activity Circadian Rhythm in a Young Scoliotic Patient Treated with Rigid Bracing: A Case Study.

Authors:  Jacopo A Vitale; Francesco Negrini; Giulia Rebagliati; Luca Giacomelli; Sabrina Donzelli; Giuseppe Banfi
Journal:  Yale J Biol Med       Date:  2019-06-27

5.  Objective Monitoring of Brace Wearing Time in Adolescents with Scheuermann's Kyphosis.

Authors:  Pouya Sharifi; Mojtaba Kamyab; Taher Babaee; Mohammad Saleh Ganjavian
Journal:  Asian Spine J       Date:  2019-08-23

6.  Adolescents' Experience during Brace Treatment for Scoliosis: A Qualitative Study.

Authors:  Mei-Chun Cheung; Derry Law; Joanne Yip; Jason Pui Yin Cheung
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.